Our Board of Directors
Our Leadership Team
TVCRP's leadership team reflects the community it serves by having multidisciplinary professionals including medical professionals, technology professionals and entrepreneurs with lived experience that informs a culturally competent approach to clinical trial design, execution and patient recruitment. Our team members are actively engaged with all relevant communities to ensure cultural, racial and ethical considerations are considered.
TVCRP's deep cultural competency and sensitivity in recruitment, patient engagement and retention strategies lead to greater engagement and participation from underrepresented groups. Many leading competitors (e.g. Medable or Parexel have diversity goals but do not incorporate the level of cultural competency that TVCRP's leadership brings.
Experience
- CEO & Chief Medical Officer of Healing Our Village, Inc.
- Chair Emeritus, Partnership for a Healthier America
- Clinical Professor, Emory University School of Medicine & Indiana University School of Medicine
- Former President and CEO, Microlslet
- Former President, Morehouse School of Medicine
- Sr. Scientific Officer, Howard Hughes Medical Institute (HHMI)
- Director, HHMI Scholars Program
- Former Acting Chief, Section on Endocrinology, Metabolism & Hypertension
- Former William K Warren Professor for Diabetes Studies at University of Oklahoma Health Sciences Center
Dr. James R. Gavin III, MD, PhD Board Member
Dr. James R. Gavin III brings exceptional leadership and deep clinical expertise to TruVision Clinical Research's mission of advancing inclusive healthcare through innovative clinical trials. He is a widely respected academic and entrepreneur in the medical community who brings a deep knowledge of childhood obesity-related illnesses and the policy and environmental influences that contribute to childhood obesity.
As Chair Emeritus of the Partnership for a Healthier America’s Board of Directors and CEO and Chief Medical Officer of Healing Our Village, Inc., Dr. Gavin has spent decades addressing disparities and driving strategies that promote accessible, inclusive healthcare. His strategic vision and ability to build consensus have established him as a trusted voice in shaping national health initiatives and organizational policy.
Throughout his distinguished career, Dr. Gavin has held pivotal leadership roles, including President of the Morehouse School of Medicine and Senior Scientific Officer at the Howard Hughes Medical Institute.
In addition, he served as a lieutenant commander in the U.S. Public Health Service, where he continues to serve as a reserve officer. Dr. Gavin belongs to a number of organizations, including the Institute of Medicine of the National Academy of Sciences, the American Diabetes Association, the American Association of Clinical Endocrinologists, the Endocrine Society, the American Society of Clinical Investigation, and the American Association of Physicians.
A passionate advocate for inclusive research, Dr. Gavin’s expertise and dedication align seamlessly with TruVision’s mission to deliver diverse, efficient, and impactful clinical trials. His leadership on the Board strengthens TruVision’s commitment to advancing global healthcare.
Experience
- Co-founder and Chief Technology Officer of CDS
- Co-founder, The Black Health Network
- Assistant Professor of Clinical Urology, Columbia University
Dr. Edward Ikeguchi MD Board Member
Dr. Edward Ikeguchi brings a rare combination of clinical, technological, and entrepreneurial excellence to TruVision’s board. As co-founder and Chief Technology Officer of CDS, he has built a legacy of translating complex clinical needs into innovative digital health solutions.
Drawing on years as an assistant professor and clinical investigator at Columbia University, Dr. Ikeguchi is well-versed in the challenges that arise throughout the research and development process. His career trajectory showcases an unwavering commitment to efficiency, innovation, and improving experiences for patients and providers alike.
Dr. Ikeguchi’s inventive mindset extends beyond medicine—he has developed and patented several medical devices and led technology commercialization efforts that streamline trial execution. With achievements that even include competing as an Olympic gold medalist, he epitomizes excellence, creative problem-solving, and perseverance.
At TruVision, he spearheads the integration of groundbreaking technology to make research participation accessible, reliable, and empowering for all stakeholders, ensuring the organization remains at the forefront of digital transformation in clinical trials.
Experience
- Professor Emeritus, UAB Heersink School of Medicine
- Member, American Society of Anesthesiologists
- Member, International Anesthesia Research Society
- Board of Directors of the Foundation for Anesthesia Education and Research
- Former Chief Physician Executive of UAB Medicine
- Former Senior Associate Dean for Clinical Affairs of UABHSOM
- Former President of University of Alabama Health Services Foundation.
- Department Chair of Anesthesiology and Perioperative Medicine for UABHSOM
- Former Chief of Anesthesiology Services for UAB Hospital
Dr. Keith Anthony (Tony) Jones MD Board Member
Dr. Keith “Tony” Jones is recognized as a thought leader in clinical medicine and health system management, lending invaluable insight to the TruVision board. As former Chief Physician Executive of UAB Medicine and a long-serving academic at the University of Alabama Heersink School of Medicine, Dr. Jones has led transformative strategies to improve clinical operations, foster team-based care, and enhance both provider and patient experiences. His visionary leadership has resulted in stronger access, better practice efficiency, and streamlined care across large-scale, multifaceted health organizations.
A trusted advisor in anesthesiology and perioperative medicine, Dr. Jones has served with distinction on the boards of the Foundation for Anesthesia Education and Research and the International Anesthesia Research Society. His experience across publicly traded healthcare companies further informs his comprehensive understanding of innovation and operational sustainability in medicine. Dr. Jones’s leadership and collaborative approach continue to help TruVision set new standards for high-quality, scalable, and inclusive clinical trials, supporting better outcomes for diverse patient communities everywhere.
Professor Emeritus, University of Alabama (UAB) Heersink School of Medicine (UABHSOM). Prior to his retirement in May 2024, Dr. Jones served as the Chief Physician Executive of UAB Medicine, Senior Associate Dean for Clinical Affairs of UABHSOM, and President of the University of Alabama Health Services Foundation (UAHSF). The UAHSF, is the Faculty Practice Plan for UAB Medicine and employs approximately 2,200 academic physicians and Advanced Practice Providers to provide medical care for the UAB Health System and fulfil the academic mission of the UABHSOM. In these leadership roles, Dr. Jones led numerous strategic and transformation initiatives to enhance team-based models of care to improve practice efficiency, provider wellness, and patient access while reducing the total cost of care. Previously from 2006 to 2017, Dr. Jones served as Chair of the Department of Anesthesiology and Perioperative Medicine for UABHSOM and Chief of Anesthesiology Services for UAB Hospital.
Dr. Jones is a member of the American Society of Anesthesiologists, where he has served on and led numerous committees. Most notable was his tenure as a member of the Board of Directors of the Foundation for Anesthesia Education and Research (FAER), a 501(c)3 organization dedicated to developing the next generation of physician-scientists in anesthesiology. He is recognized as one of the specialty’s key thought leaders, serving on the inaugural Board of Directors of the American Society for Enhanced Recovery and as a permanent and Ad Hoc member of several National Institutes of Health Study Sections. Dr. Jones previously served on the Board of Directors of the American Medical Group Association and is currently serving on the Board of Directors for Inventurus Knowledge Solution (IKS) Health and Humacyte, publicly traded companies in the healthcare industry.
Experience
- Designed Link2ConsultVMS
- Co-founded MBH Solutions
- Board Member & Trustee, New York City School Construction Authority
- Board Member, New York Department of Youth and Community Development
Peter McCree Board Member
Peter McCree’s expertise in technology, operations, and strategic business growth makes him an invaluable asset to TruVision’s leadership. With more than three decades of experience across the IT industry, he has demonstrated unmatched skill in building and scaling firms, driving innovation, and turning ideas into thriving enterprises.
Mr. McCree’s most notable achievements include designing the Link2ConsultVMS vendor management system—a workforce management platform—and leading the commercialization of several software products that elevated performance for major organizations.
As co-founder and former CEO of MBH Solutions, Mr. McCree grew one of the nation’s largest minority-owned consulting groups, demonstrating a proven ability to foster profitability and create impactful business strategies.
His trusted input as a trustee and board member of the New York City School Construction Authority (which has a $20 billion five year capital plan), and the New York Department of Youth and Community Development showcases his ability to manage complex, high-value projects.
At TruVision, Mr. McCree’s operational vision and technological acumen help ensure the organization’s long-term sustainability, efficiency, and leadership in the evolving clinical research landscape.
Experience
- Associate Professor, Department of Preventative Medicine, University of Tennessee
- Member, American Urology Association
- Member, American Association of Clinical Urologists
- Member National Medical Association
- Member, R. Frank Jones Urological Society
Dr. Walter Rayford MD, Phd, MBA Board Member
Dr. Walter Rayford brings deep expertise in urologic oncology, a robust research portfolio, and a passion for health equity to TruVision’s board.
With decades of experience spanning prostate cancer, benign prostate hypertrophy, and health disparities, Dr. Rayford stands as an influential voice driving thoughtful clinical discovery and real-world impact.
His clinical practice and research have produced numerous peer-reviewed publications, helping to inform best practices and shape the landscape of cancer care for underserved populations.
As a urologic oncology fellow at the National Cancer Institute and an Associate Professor in the Department of Preventive Medicine at the University of Tennessee, Dr. Rayford has championed advanced therapies while mentoring the next generation of healthcare leaders. He is lauded for championing inclusive trial design and patient recruitment strategies that help ensure groundbreaking research reaches those most in need.
At TruVision, Dr. Rayford leverages his expertise and insight to help expand clinical outreach, develop innovative engagement models, and uphold the organization’s high scientific and ethical standards—driving forward the promise of personalized, effective therapies for all.
Experience
- Founder of Jasper Urology Associates
- President, Northwest Alabama Lithotripsy LLC
- President, Alabama Sexual Medicine Specialists LLC
- Member, Congressional Black Caucus scholarship Committee
- Member, Former President, R. Frank Jones Urological Society
- Former Director, Ambulatory Urology at Harlem Hospital
- Former Chief of Urology at North General Hospital
- Former Chief of Urologic Oncology at the Ralph Lauren Cancer Center
- Former Associate Director of Neuro-urology at Maimonides Medical Center
- Co-founder, The Black Health Network
Dr. Brian Stone, MD, FACS CEO & Chairman
Dr. Brian Stone's journey began in Birmingham, Alabama, where a simple observation during his medical training would eventually transform clinical research forever. While completing his urology residency at Montefiore Medical Center in New York, he noticed something troubling: significant racial disparities in prostate cancer outcomes among patients of color. This wasn't just a statistic—it was a call to action.
Determined to make a difference, Dr. Stone secured funding for a groundbreaking free prostate cancer screening program targeting men of African descent in New York City. Through partnerships with the Baptist Ministers Association and Prince Hall Masons, he successfully screened over 5,000 men, but the data revealed a deeper problem. Even when controlling for early detection, socioeconomic status, and insurance coverage, outcomes remained poor for African American men with prostate cancer.
The answer became clear: clinical trials lacked diverse representation, making treatment algorithms less effective for underrepresented populations. This revelation sparked Dr. Stone's mission to revolutionize clinical research.
During his tenure at Columbia College of Physicians and Surgeons from 1994 to 2009, Dr. Stone served in multiple leadership roles across New York City hospitals while working alongside Dr. Harold Freeman at Harlem Hospital. He witnessed firsthand how health disparities affected underserved communities. These experiences led him to co-create the Black Health Network in 1996—the first health information website for African Americans.
What started as a health information platform quickly evolved into something more powerful: a clinical trial management company. When Amgen needed to recruit African American patients for their pivotal prostate cancer trials, they turned to Dr. Stone. Despite the high-risk nature of using research-naïve sites, his innovative approach successfully guided 25 African American urologist investigators to become the highest recruiters of African American patients for the Amgen Abarelix trial.
Today, as CEO and Chairman of TruVision, Dr. Stone continues his mission to ensure clinical research serves all populations. His leadership has transformed how the industry approaches diversity in clinical trials, proving that inclusive research is essential for developing treatments that work for everyone.
About Us
We are the leader in innovation & execution of comprehensive patient recruitment and
clinical trial management.